SLC9A1 and coronary artery disorder: Further characterization of ApoE−/−ANRIL mice and human atherosclerotic tissue samples identified the ANRIL–miR-181b-5p–TMEM106B-NHE1–lysosomal pH axis as the underlying molecular pathogenic mechanism for CAD.